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This laboratory was founded in 1994 with the aim of linking (bio)chemical research and clinical medicine. Thus, the
scope of our research encompasses the structure, function and pathophysiological significance of various biomolecules
and bioreactions in relation to human diseases, and the application ofmolecular techniques to clinical diagnosis and thera-
py. Our current interest is focused on the role ofpoly(ADP-ribosyl)ation in protection ofgenome from apoptosis-inducing
stresses, and the molecular etiology ofneurodegenerative disorders including Alzheimer's disease and Parkinson's disease.
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Role of Poly(ADP-ribose) Synthetase in Neu-
ronal Cell Death
Po1y(ADP-ribose) synthetase (PARS) is a nuclear en-
zyme that, upon activation by DNA single-strand breaks,
forms (ADP-ribose)n chains from [3-nicotinamide adenine
dinucleotide (NAD) on acceptor proteins, including his-
tones and PARS itself. Po1y(ADP-ribose) is known to be
involved in various physiological and pathological events
such as DNA repair, cell differentiation, cell cycle, and cell
death. The excessive activation ofPARS leads to depletion
ofcellular NAD+. The depletion ofNAD+, a co-enzyme in
energy metabolism, results in reduction ofATP generation,
while ATP is used for replenishment of NAD+. This "en-
ergy crisis" is considered to be causative of apoptotic and
necrotic cell death.
We studied, using models derived from primary cell
cultures of rat brain, ro1e(s) of PARS in the neuronal cell
death in Alzheimer's disease (AD) and cerebral infarc-
tion. In the AD model, cortical neurons became mostly
apoptotic after exposure to A[3 amyloid fibrils. The A[3
fibrils treatment enhanced mitochondrial generation of
reactive oxygen species (ROS). In the cerebral infarc-
tion model, cortical neurons became partly apoptotic and
partly necrotic after oxygen-glucose deprivation. This
treatment induced mitochondrial membrane depolariza-
tion and the opening ofpermeability transition pore (pTP),
through which apoptotic factors such as cytochrome c and
apoptosis-inducing factor (AlF) were released. In both
AD and cerebral infarction models, PARS was activated
in a dose- and time-dependent manner, resulting in the de-
crease ofNAD+ content. Addition ofPARS inhibitors such
as 1,5-dihydroxyisoquino1ine and benzamide suppressed
NAD+ depletion, and also attenuated the mitochondrial
injury. These in vitro models strongly suggest that PARS
activation plays a critical role in the ROS-mediated neu-
ronal cell death in the pathological conditions such as AD
and cerebral infarction.
Functional Characterization of Septin 3
Septin 3 is a novel member of the septin subfamily with
GTPase domain. The septin 3 gene was originally cloned
with a phenotype of up-regulation during neuronal dif-
ferentiation of the human teratocarcinoma cell line NT2.
Septin 3 has, at least, two isoforms, A and B, that are pro-
duced by the alternative splicing of a single transcript. We
studied the physiological and pathological roles of septin 3
isoforms. Using antibodies specific for the isoforms A and
B, we found that both isoforms were abundantly expressed
in normal human brain. We further investigated intrace1-
1u1ar localization and interaction of the two isoforms in
HeLa cells, transfected separately or together, by use ofthe
antibodies in immunohistochemistry and immunoprecipi-
tation. Both isoforms A and B were found to form fibrous
structures in the cytoplasm, and the structures were to be
composed ofhomologous as well as heterologous isoforms
of septin 3. We also analyzed a genetic association of
septin 3 po1ymorphisms with Alzheimer's disease (AD),
Parkinson's disease (PD), and Lewy body variant (LBV)
of AD. Genotyping of microsatellite polymorphisms in
exon 11 indicated a significant difference in long/short al-
lelic distribution between AD and control, suggesting a
role played by septin 3 in pathogenesis ofAD, but not PD
orLBV
Overexpressiom of CYP2D6 Attenuates the
Toxicity of MPP+ in Actevity Dividing and
DiffuentiaredPC12Ce&
Clonal pheochromocytoma cell1ines overexpress-
ing cytochrome P450 2D6 (CYP2D6) were established.
CYP2D6 was localized in the endoplasmic reticulum, and
its enzymatic activity in the microsomal fraction was con-
firmed by using high performance liquid chromatography
analysis with [guanidine-14C]debrisoquine as a substrate.
Overexpression of CYP2D6 protected cells against the
toxic effects of 1-methyl-4-pheny1pyridinium ion (MPP+)
at the concentration range of 20--40 I-lM, as assessed by
the 3-(4,5-dimethy1thiazol-2-y1)-2,5-diphenyltetrazolium
bromide (MTT) assay. Further, reactive oxygen species
generation was suppressed in the mitochondria. The cyto-
toxicity of I-methyl-4-phenyl-l ,2,3,6-tetrahydropyridine
(MPTP) was unchanged in cells overexpressing CYP2D6
versus mock-transfected controls at concentrations up to
500 I-lM. These results suggest that the lowered enzyme
activity of CYP2D6 in individuals, termed "poor metabo-
1izers" may represent a risk factor from exposure to select
neurotoxicants.
Figure 1. Mitochondrial generation of ROS after exposure to MPP+or
MPTP.
Clonal cells were treated with a reduced fonn of chloromethyltetra-
methylrosamine before (a) after a 24-h incubation with 20 (.1M MPP+
(b) or 500 (.1M MPTP (c). Mitochondrial ROS are visualized by oxi-
dized chloromethyltetramethylrosamine (Scale bar = 40 ,.un).
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